1. Home
  2. CELZ vs SHPH Comparison

CELZ vs SHPH Comparison

Compare CELZ & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$2.31

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$1.01

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CELZ
SHPH
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.2M
IPO Year
2008
2022

Fundamental Metrics

Financial Performance
Metric
CELZ
SHPH
Price
$2.31
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
76.3K
179.5K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
32.08
N/A
EPS
N/A
N/A
Revenue
$6,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.12
52 Week High
$6.25
$5.59

Technical Indicators

Market Signals
Indicator
CELZ
SHPH
Relative Strength Index (RSI) 59.40 58.34
Support Level $2.05 $0.80
Resistance Level $2.42 $1.06
Average True Range (ATR) 0.18 0.13
MACD -0.00 0.03
Stochastic Oscillator 69.81 72.24

Price Performance

Historical Comparison
CELZ
SHPH

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Share on Social Networks: